Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Food Chem Toxicol ; 48(11): 3221-6, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20813150

ABSTRACT

The acute toxicity (LD(50)) of insecticide methomyl and its effects on male reproduction in rats were carried out. Methomyl was given orally to male rats daily for 65 successive days at two doses (0.5 and 1.0 mg kg(-1) b.wt., corresponding to 1/40 and 1/20 LD(50)) alone and in combination with folic acid (1.1 mg kg(-1) b.wt., corresponding to acceptable daily intake, ADI). Fertility index, weight of sexual organs, semen picture, serum testosterone level and histopathology of testes were the parameters used to evaluate the reproductive efficiency of treated rats. The reversibility of methomyl effects was also studied after 65 days post-administration. The oral LD(50) of methomyl was 20.0 mg kg(-1) b.wt. in male rats. Methomyl significantly decreased the fertility index, weight of testes and accessory male sexual glands, serum testosterone level and sperm motility and count, but increased sperm cell abnormality. It induced testicular lesions characterized by moderate to severe degenerative changes of seminiferous tubules and incomplete arrest of spermatogenesis. These toxic effects were not persistent (reversible). Coadministration of folic acid with methomyl decreased its reproductive toxicity. A great attention should be taken during field application of methomyl to avoid its deleterious effects in farm animals and occupationally exposed humans.


Subject(s)
Fertility/drug effects , Folic Acid/pharmacology , Insecticides/toxicity , Methomyl/toxicity , Vitamin B Complex/pharmacology , Administration, Oral , Animals , Genitalia/drug effects , Genitalia/pathology , Lethal Dose 50 , Male , Organ Size/drug effects , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects , Sperm Count , Sperm Motility/drug effects , Sperm Motility/physiology , Spermatozoa/abnormalities , Spermatozoa/drug effects , Spermatozoa/physiology , Testis/drug effects , Testis/pathology , Testosterone/blood
2.
J Vet Med A Physiol Pathol Clin Med ; 52(6): 287-91, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16050910

ABSTRACT

Prophylactic and curative capacity of water soluble formulation of Diclazuril (Diclosol 1%) and feed additive form (Clinacox, 0.5%) were tested against Eimeria infection in broiler chickens. Such testing was performed both experimentally and in the field. Toltrazuril (Baycox, 2.5%) was used as reference control drug. Water soluble formulation of Diclazuril induced a marked inhibitory effect on the different stages of the parasite life cycle in experimentally infected treated birds especially when applied on the day when blood first appeared in the faeces [fifth day post-infection (d.p.i.)] as well as on the second day of blood dropping (6 d.p.i.). Both tested dosage levels of Diclazuril water soluble formulation in drinking water (5 and 10 ppm) showed the same effect in controlling coccidial infection and reducing the total oocyst numbers, lesion and faecal scores. Moreover, there was no significant difference in the efficacy of water soluble form of Diclazuril and the reference control drug (Toltrazuril, 25 ppm). In addition, testing the water soluble formulation (5 ppm) in naturally infected poultry farm (20,000 birds), showed the same anticoccidial effect observed when using Toltrazuril, as a treatment for coccidiosis. In conclusion, addition of Diclazuril at the dose of 5 ppm in the drinking water of naturally coccidia infected bird induced the same effect as 25 ppm of Toltrazuril as a treatment for coccidiosis in chickens.


Subject(s)
Chickens/parasitology , Coccidiosis/veterinary , Coccidiostats/therapeutic use , Nitriles/therapeutic use , Poultry Diseases/drug therapy , Triazines/therapeutic use , Administration, Oral , Animals , Coccidiosis/drug therapy , Coccidiosis/prevention & control , Coccidiostats/chemistry , Drinking , Nitriles/chemistry , Poultry Diseases/prevention & control , Random Allocation , Solubility , Treatment Outcome , Triazines/chemistry
3.
Vet Res Commun ; 28(6): 515-24, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15509025

ABSTRACT

This study examined the disposition kinetics and bioavailability of florfenicol after intravenous (i.v.), intramuscular (i.m.) and oral administration to rabbits at a dose of 30 mg/kg BW. Serial blood samples were collected through an indwelling catheter intermittently for 24 h for various routes. Plasma antibacterial concentrations were determined using a microbiological assay method with Bacillus subtilis ATCC 6633 as a reference organism. Plasma concentration-time data generated in the present study were analysed by non-compartmental methods based on statistical moment theory. Following i.v. administration, the overall elimination half-life (t1/2beta) was 1.54 h, mean residence time (MRT) was 1.69 h, mean volume of distribution at steady-state (Vdss) was 0.57 L/kg, and total body clearance (Cltot) was 0.34 L/kg/h. After i.m. and oral dosing, the terminal part of the curve should correspond to the absorption phase, instead of to the elimination phase, with terminal half-lives of 3.01 and 2.57 h, respectively. The mean absorption time (MAT) was 2.65 h for i.m. and 2.01 h for oral administration. Elimination rate constants differed with i.v., i.m. and oral administrations, suggesting a flip-flop situation. The observed mean peak plasma concentrations (Cmax obs) were 21.65 and 15.14 microg/ml achieved at a post-injection time (Tmax obs) of 0.5 h following i.m. and oral dosing, respectively. The absolute systemic availabilities were 88.25% and 50.79%, respectively, and the extent of plasma protein binding percent was 11.65%.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacokinetics , Rabbits/metabolism , Thiamphenicol/analogs & derivatives , Thiamphenicol/administration & dosage , Thiamphenicol/pharmacokinetics , Administration, Oral , Animals , Anti-Bacterial Agents/blood , Area Under Curve , Biological Availability , Half-Life , Injections, Intramuscular/veterinary , Injections, Intravenous/veterinary , Protein Binding , Thiamphenicol/blood
4.
Pharmacol Res ; 50(2): 137-42, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15177301

ABSTRACT

The effect of alpha-tocopherol, simvastatin and both on male fertility in hypercholesterolemic rats was studied. Induction of hypercholesterolemia was done by feeding rats on a diet containing 1% cholesterol for 30 days. Hypercholesterolemic rats were orally given alpha-tocopherol (3 mg kg(-1) BW) or simvastatin (1 mg kg(-1) BW) or both for 65 days. Fertility index, serum testosterone level, sex organs weight, semen analysis and histopathological examination of testes, seminal vesicles and prostate glands were the parameters used to evaluate the reproductive efficiency of rats. In hypercholesterolemic rats (control +ve), there was a marked decrease in fertility index, testicular weight, sperm cell count, and percentages of sperm motility and viability associated with a significant increase in sperm cell abnormalities. Oral administration of either alpha-tocopherol or simvastatin to hypercholesterolemic rats for 65 days significantly improved the fertility index, testicular weight and semen quality. Concomitant administration of alpha-tocopherol and simvastatin to hypercholesterolemic rats markedly increased fertility index and sperm motility and viability associated with a significant reduction of sperm cell abnormalities. Histopathological examination revealed that testes of hypercholesterolemic rats (control +ve) had degenerated, non-functioning and atrophied seminiferous tubules associated with arrest of spermatogenesis. Oral administration of alpha-tocopherol and simvastatin concomitantly to hypercholesterolemic rats resulted in active mature and full functioning seminiferous tubules. In conclusion, concomitant administration of alpha-tocopherol and simvastatin to hypercholesterolemic male rats improved their reproductive efficiency and produced additional protection against reduced fertility induced by hypercholesterolemia.


Subject(s)
Hypercholesterolemia/drug therapy , Infertility, Male/drug therapy , Simvastatin/pharmacology , alpha-Tocopherol/pharmacology , Administration, Oral , Animals , Capsules , Cholesterol, Dietary/administration & dosage , Cholesterol, Dietary/adverse effects , Cholesterol, Dietary/pharmacology , Diet , Drug Administration Schedule , Drug Therapy, Combination , Female , Gelatin , Hypercholesterolemia/chemically induced , Hypercholesterolemia/complications , Infertility, Male/complications , Male , Organ Size/drug effects , Prostate/drug effects , Rats , Reproduction/drug effects , Reproduction/physiology , Semen/chemistry , Semen/drug effects , Seminiferous Tubules/drug effects , Seminiferous Tubules/pathology , Simvastatin/administration & dosage , Simvastatin/therapeutic use , Sperm Count/methods , Sperm Motility/drug effects , Spermatozoa/abnormalities , Spermatozoa/drug effects , Testis/chemistry , Testis/drug effects , Testis/ultrastructure , Testosterone/blood , Time Factors , alpha-Tocopherol/administration & dosage , alpha-Tocopherol/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...